SiriusPoint (SPNT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Net income for Q2 2026 rose to $69 million, up 44% year-over-year, with operating ROE at 13.8% and at the upper end of the 12%-15% target range.
Core gross written premium increased 6% in Q2, led by a 15% rise in Insurance & Services and a 9% decline in Reinsurance.
Book value per diluted share (excluding AOCI) increased 3% in Q2 and 8% year-to-date, reaching $19.48.
$295 million in capital returned to shareholders year-to-date, including $95 million in share repurchases and preference share redemption.
Strategic focus on specialty underwriting, diversification, and disciplined capital allocation has resulted in a more balanced and resilient portfolio.
Financial highlights
Q2 2026 core combined ratio was 91.4%; underwriting income was $55 million; operating net income was $79 million ($0.67 per diluted share).
Half-year operating net income was $165 million, with operating EPS up 17% year-over-year to $1.37.
Net investment income for Q2 was $65.5 million; net investment gains were $7.9 million.
Book value per diluted share (ex. AOCI) at June 30, 2026: $19.48; tangible book value per share: $17.98.
BSCR solvency ratio estimated at 239%, with leverage ratio reduced to 22.9%.
Outlook and guidance
On track to deliver full-year OUE ratio of approximately 7%, at the upper end of guidance.
Management expects continued growth in Insurance & Services, with focus on niche MGA partnerships and disciplined underwriting.
Confident in ability to deliver across-the-cycle ROE target of 12%-15%.
Latest events from SiriusPoint
- Q2 and HY 2026 results show strong ROE, disciplined growth, and robust capital position.SPNT
Investor presentation29 Jul 2026 - FY25 net income up 141%, 16% premium growth, and 16.2% ROE with major capital actions.SPNT
Q4 20258 Jul 2026 - Q1 2025 saw strong premium growth, stable earnings, and upgraded ratings despite catastrophe losses.SPNT
Q1 20258 Jul 2026 - Q1 2026 net income hit $102.3M, core combined ratio 88.9%, and $242M capital returned.SPNT
Q1 20268 May 2026 - 2026 AGM features director elections, say-on-pay, auditor reappointment, and new share plan.SPNT
Proxy filing10 Apr 2026 - Q2 net income $109.9M, book value up 7.2%, and share buyback authorization at $306.3M.SPNT
Q2 20242 Feb 2026 - Q3 2024 saw improved underwriting, strong investment income, and robust capital strength.SPNT
Q3 202417 Jan 2026 - Ninth straight underwriting profit, 14.6% ROE, and 9.8% book value growth in FY24.SPNT
Q4 20249 Dec 2025 - 2025 AGM features director elections, say-on-pay, auditor approval, and highlights strong 2024 results.SPNT
Proxy Filing2 Dec 2025